203 related articles for article (PubMed ID: 23881886)
1. "Spiceophrenia": a systematic overview of "spice"-related psychopathological issues and a case report.
Papanti D; Schifano F; Botteon G; Bertossi F; Mannix J; Vidoni D; Impagnatiello M; Pascolo-Fabrici E; Bonavigo T
Hum Psychopharmacol; 2013 Jul; 28(4):379-89. PubMed ID: 23881886
[TBL] [Abstract][Full Text] [Related]
2. Psychosis and synthetic cannabinoids.
Deng H; Verrico CD; Kosten TR; Nielsen DA
Psychiatry Res; 2018 Oct; 268():400-412. PubMed ID: 30125871
[TBL] [Abstract][Full Text] [Related]
3. Synthetic cannabinoid JWH-018 and psychosis: an explorative study.
Every-Palmer S
Drug Alcohol Depend; 2011 Sep; 117(2-3):152-7. PubMed ID: 21316162
[TBL] [Abstract][Full Text] [Related]
4. A New Differential Diagnosis: Synthetic Cannabinoids-Associated Acute Renal Failure.
Gudsoorkar VS; Perez JA
Methodist Debakey Cardiovasc J; 2015; 11(3):189-91. PubMed ID: 26634029
[TBL] [Abstract][Full Text] [Related]
5. Synthetic Cannabinoids-Further Evidence Supporting the Relationship Between Cannabinoids and Psychosis.
Fattore L
Biol Psychiatry; 2016 Apr; 79(7):539-48. PubMed ID: 26970364
[TBL] [Abstract][Full Text] [Related]
6. Do police arrestees substitute legal highs for other drugs?
Wilkins C; Parker K; Prasad J; Jawalkar S
Int J Drug Policy; 2016 May; 31():74-9. PubMed ID: 26948501
[TBL] [Abstract][Full Text] [Related]
7. Psychosis and severe rhabdomyolysis associated with synthetic cannabinoid use: A case report.
Durand D; Delgado LL; de la Parra-Pellot DM; Nichols-Vinueza D
Clin Schizophr Relat Psychoses; 2015 Jan; 8(4):205-8. PubMed ID: 23518784
[TBL] [Abstract][Full Text] [Related]
8. International trends in spice use: Prevalence, motivation for use, relationship to other substances, and perception of use and safety for synthetic cannabinoids.
Loeffler G; Delaney E; Hann M
Brain Res Bull; 2016 Sep; 126(Pt 1):8-28. PubMed ID: 27108542
[TBL] [Abstract][Full Text] [Related]
9. [Acute Psychosis after Consumption of Synthetic Cannabinoids].
Mörkl S; Blesl C; Wurm WE; Tmava A
Fortschr Neurol Psychiatr; 2016 Mar; 84(3):150-4. PubMed ID: 27029042
[TBL] [Abstract][Full Text] [Related]
10. A survey of synthetic cannabinoid consumption by current cannabis users.
Gunderson EW; Haughey HM; Ait-Daoud N; Joshi AS; Hart CL
Subst Abus; 2014; 35(2):184-9. PubMed ID: 24821356
[TBL] [Abstract][Full Text] [Related]
11. The behavioral profile of spice and synthetic cannabinoids in humans.
Müller HH; Kornhuber J; Sperling W
Brain Res Bull; 2016 Sep; 126(Pt 1):3-7. PubMed ID: 26548494
[TBL] [Abstract][Full Text] [Related]
12. Adverse effects after the use of JWH-210 - a case series from the EU Spice II plus project.
Hermanns-Clausen M; Kithinji J; Spehl M; Angerer V; Franz F; Eyer F; Auwärter V
Drug Test Anal; 2016 Oct; 8(10):1030-1038. PubMed ID: 26768345
[TBL] [Abstract][Full Text] [Related]
13. A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment.
Tait RJ; Caldicott D; Mountain D; Hill SL; Lenton S
Clin Toxicol (Phila); 2016; 54(1):1-13. PubMed ID: 26567470
[TBL] [Abstract][Full Text] [Related]
14. Acute mental disturbance caused by synthetic cannabinoid: a potential emerging substance of abuse in Hong Kong.
Tung CK; Chiang TP; Lam M
East Asian Arch Psychiatry; 2012 Mar; 22(1):31-3. PubMed ID: 22447803
[TBL] [Abstract][Full Text] [Related]
15. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
Martinotti G; Santacroce R; Papanti D; Elgharably Y; Prilutskaya M; Corazza O
CNS Neurol Disord Drug Targets; 2017; 16(5):567-575. PubMed ID: 28412921
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis.
Bassir Nia A; Medrano B; Perkel C; Galynker I; Hurd YL
J Psychopharmacol; 2016 Dec; 30(12):1321-1330. PubMed ID: 27462088
[TBL] [Abstract][Full Text] [Related]
17. Cannabis and the brain.
Castle DJ; Ames FR
Aust N Z J Psychiatry; 1996 Apr; 30(2):179-83. PubMed ID: 8811260
[TBL] [Abstract][Full Text] [Related]
18. Cannabis-Induced Psychosis and an Antipsychotic-Induced Seizure: A Case Report.
Perera T; Webler R
Prim Care Companion CNS Disord; 2017 Feb; 19(1):. PubMed ID: 28157276
[No Abstract] [Full Text] [Related]
19. [Can cannabis use increase the risk for schizophrenic psychoses?].
Bugra H; Rapp C; Studerus E; Aston J; Borgwardt S; Riecher-Rössler A
Fortschr Neurol Psychiatr; 2012 Nov; 80(11):635-43. PubMed ID: 23139065
[TBL] [Abstract][Full Text] [Related]
20. "Smoking" guns: Questions. “Smoking” guns: Answers.
Cooks T; Davis TK; Hu J; Metheny R; Schwartz M; Gerona R
Pediatr Nephrol; 2016 Jan; 31(1):61-2, 63-6. PubMed ID: 25330878
[No Abstract] [Full Text] [Related]
[Next] [New Search]
